Free Trial

PDS Biotechnology (PDSB) Short Interest Ratio & Short Volume

PDS Biotechnology logo
$1.26 +0.01 (+0.80%)
Closing price 04:00 PM Eastern
Extended Trading
$1.29 +0.03 (+2.70%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDS Biotechnology Short Interest Data

PDS Biotechnology (PDSB) has a short interest of 3.86 million shares, representing 11.40% of the float (the number of shares available for trading by the public). This marks a -17.34% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 529,994 shares to cover all short positions.

Current Short Interest
3,860,000 shares
Previous Short Interest
4,670,000 shares
Change Vs. Previous Month
-17.34%
Dollar Volume Sold Short
$4.75 million
Short Interest Ratio
6.3 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
38,193,000 shares
Short Percent of Float
11.40%
Today's Trading Volume
221,897 shares
Average Trading Volume
529,994 shares
Today's Volume Vs. Average
42%
Short Selling PDS Biotechnology?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for PDS Biotechnology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PDSB Short Interest Over Time

PDSB Days to Cover Over Time

PDSB Percentage of Float Shorted Over Time

Remove Ads

PDS Biotechnology Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20253,860,000 shares $4.75 million -17.3%11.4%6.3 $1.23
2/28/20254,670,000 shares $6.21 million +20.7%13.8%7.4 $1.33
2/15/20253,870,000 shares $6.04 million -3.5%11.4%9.8 $1.56
1/31/20254,010,000 shares $6.58 million -2.4%N/A10.6 $1.64
1/15/20254,110,000 shares $5.96 million +1.2%N/A10.3 $1.45
12/31/20244,060,000 shares $6.62 million -4.0%N/A10.1 $1.63
12/15/20244,230,000 shares $7.78 million +9.0%N/A9.5 $1.84
11/30/20243,880,000 shares $8.50 million +0.3%N/A9.2 $2.19
11/15/20243,870,000 shares $7.78 million -13.4%N/A9.9 $2.01
10/31/20244,470,000 shares $14.26 million -6.9%N/A14.3 $3.19
10/15/20244,800,000 shares $15.50 million +0.2%N/A16.1 $3.23
9/30/20244,790,000 shares $18.30 million +3.9%N/A14.2 $3.82
9/15/20244,610,000 shares $13.83 million -3.2%N/A11.2 $3.00
8/31/20244,760,000 shares $15.23 million -5.4%N/A10.7 $3.20
8/15/20245,030,000 shares $16.25 million -0.8%N/A10.4 $3.23
7/31/20245,070,000 shares $18.05 million -11.1%N/A8.8 $3.56
7/15/20245,700,000 shares $24.08 million -18.6%N/A9.1 $4.23
6/30/20247,000,000 shares $20.51 million +3.7%N/A10.4 $2.93
6/15/20246,750,000 shares $18.80 million +0.6%N/A8.7 $2.79
5/31/20246,710,000 shares $20.00 million -2.0%N/A8.2 $2.98
5/15/20246,850,000 shares $23.98 million -0.2%N/A7.3 $3.50
4/30/20246,860,000 shares $22.98 million -3.9%N/A7.6 $3.35
4/15/20247,140,000 shares $20.13 million +16.1%N/A7.7 $2.82
3/31/20246,150,000 shares $24.35 million +11.6%N/A6.7 $3.96
3/15/20245,510,000 shares $27.00 million +9.5%N/A7 $4.90
2/29/20245,030,000 shares $33.15 million +0.4%N/A7.1 $6.59
2/15/20245,010,000 shares $27.35 million -5.1%N/A8.4 $5.46
1/31/20245,280,000 shares $28.25 million +1.9%N/A8.6 $5.35
1/15/20245,180,000 shares $22.38 million +5.5%N/A9.2 $4.32
12/31/20234,910,000 shares $24.40 million +4.7%N/A9.8 $4.97
12/15/20234,690,000 shares $23.92 million -3.5%N/A9 $5.10
11/30/20234,860,000 shares $25.56 million -7.4%N/A9.9 $5.26
11/15/20235,250,000 shares $33.18 million -4.9%N/A11.3 $6.32
10/31/20235,520,000 shares $23.02 million -6.3%N/A12 $4.17
10/15/20235,890,000 shares $26.56 million +11.8%N/A12.3 $4.51
9/30/20235,270,000 shares $26.61 million +15.3%N/A9.9 $5.05
9/15/20234,570,000 shares $24.40 million +6.5%N/A7.9 $5.34
8/31/20234,290,000 shares $25.18 million +7.8%N/A6.4 $5.87
8/15/20233,980,000 shares $23.40 million +0.5%N/A3.9 $5.88
7/31/20233,960,000 shares $22.63 million -5.5%N/A4.3 $5.72
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
7/15/20234,190,000 shares $21.49 million +8.0%N/A4.7 $5.13
6/30/20233,880,000 shares $19.52 million +32.0%N/A4.5 $5.03
6/15/20232,940,000 shares $18.29 million +9.7%N/A3.5 $6.22
5/31/20232,680,000 shares $25.67 million +27.0%N/A3.9 $9.58
5/15/20232,110,000 shares $14.62 million No ChangeN/A6.1 $6.93
4/30/20232,110,000 shares $12.83 million +3.4%N/A5.9 $6.08
4/15/20232,040,000 shares $14.06 million +2.5%N/A4.9 $6.89
3/31/20231,990,000 shares $12.24 million +7.6%N/A4.3 $6.15
3/15/20231,850,000 shares $12.27 million +1.7%N/A3.1 $6.63
2/28/20231,820,000 shares $13.92 million +15.2%N/A3 $7.65
2/15/20231,580,000 shares $13.84 million -3.7%N/A2.5 $8.76
1/31/20231,640,000 shares $13.66 million +9.3%N/A1.6 $8.33
1/15/20231,500,000 shares $15.57 million +5.6%N/A1.5 $10.38
12/30/20221,420,000 shares $18.74 million +34.0%N/A1.4 $13.20
12/15/20221,060,000 shares $10.01 million -2.8%N/A1.3 $9.44
11/30/20221,090,000 shares $9.84 million -26.4%N/A1.4 $9.03
11/15/20221,480,000 shares $12.85 million +5.7%N/A2.1 $8.68
10/31/20221,400,000 shares $7.34 million +6.9%N/A5.7 $5.24
10/15/20221,310,000 shares $5.23 million +0.8%N/A5.4 $3.99
9/30/20221,300,000 shares $3.86 million -6.5%N/A5.9 $2.97
9/15/20221,390,000 shares $5.45 million -6.1%N/A6 $3.92
8/31/20221,480,000 shares $6.20 million -1.3%N/A5.3 $4.19
8/15/20221,500,000 shares $8.69 million -10.2%N/A2.4 $5.79
7/31/20221,670,000 shares $7.15 million -5.1%N/A2.5 $4.28
7/15/20221,760,000 shares $7.00 million -6.9%N/A2.7 $3.98
6/30/20221,890,000 shares $6.90 million +0.5%N/A3 $3.65
6/15/20221,880,000 shares $6.07 million +20.5%N/A3 $3.23
5/31/20221,560,000 shares $6.12 million +4.0%N/A2.6 $3.92
5/15/20221,500,000 shares $6.84 million +2.0%N/A5.6 $4.56
4/30/20221,470,000 shares $8.13 million +1.4%N/A5.8 $5.53
4/15/20221,450,000 shares $8.12 million +0.7%N/A4.6 $5.60
3/31/20221,440,000 shares $8.91 million +0.7%N/A4.2 $6.19
3/15/20221,430,000 shares $7.81 million +14.4%N/A4 $5.46
2/28/20221,250,000 shares $7.48 million +50.7%N/A3.2 $5.98
2/15/2022829,500 shares $5.72 million +32.5%N/A2.1 $6.90
1/31/2022625,900 shares $3.73 million -5.5%N/A1.5 $5.96
1/15/2022662,000 shares $4.51 million +4.8%N/A1.8 $6.82
12/31/2021631,600 shares $5.12 million -10.6%N/A1.7 $8.10
12/15/2021706,800 shares $6.34 million +33.4%N/A1.7 $8.97
11/30/2021529,800 shares $5.22 million -26.5%N/A1.2 $9.85
11/15/2021720,300 shares $7.86 million -6.7%N/A1.6 $10.91
10/29/2021772,000 shares $9.29 million -5.0%N/A1.6 $12.04
10/15/2021812,700 shares $10.02 million +66.2%N/A1.7 $12.33
9/30/2021489,100 shares $7.29 million +10.2%N/A1 $14.90
9/15/2021443,900 shares $6.79 million -1.6%N/A0.8 $15.30
8/31/2021451,100 shares $7.01 million +11.9%2.0%0.5 $15.55
8/13/2021403,200 shares $4.29 million -19.3%1.8%0.4 $10.65
7/30/2021499,600 shares $5.33 million -18.7%2.3%0.3 $10.67
7/15/2021614,500 shares $6.00 million -26.5%2.9%0.3 $9.77
6/30/2021836,400 shares $10.50 million -31.4%4.2%0.5 $12.55
URGENT: Someone's Moving Gold Out of London... (Ad)

People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.

Go here to learn about my Top Four picks for the coming bull mania.
6/15/20211,220,000 shares $11.22 million +20.8%5.6%0.7 $9.20
5/28/20211,010,000 shares $12.32 million +18.8%5.7%0.5 $12.20
5/14/2021850,500 shares $3.81 million +27.8%N/A0.4 $4.48
4/30/2021665,600 shares $3.80 million -29.0%N/A0.4 $5.71
4/15/2021937,100 shares $4.92 million +207.3%N/A0.6 $5.25
3/31/2021305,000 shares $1.30 million -62.6%N/A0.2 $4.25
3/15/2021816,300 shares $4.61 million +73.6%N/A0.5 $5.65
2/26/2021470,300 shares $2.09 million +38.8%N/A0.5 $4.45
2/12/2021338,900 shares $1.90 million -26.2%N/A0.4 $5.61
1/29/2021458,900 shares $1.18 million +19.2%N/A0.6 $2.57
1/15/2021385,100 shares $1.06 million -40.7%N/A0.8 $2.76
12/31/2020648,900 shares $1.45 million +39.4%N/A1.4 $2.23
12/15/2020465,400 shares $981,994.00 +8.1%N/A1 $2.11
11/30/2020430,400 shares $912,448.00 +10.5%N/A0.9 $2.12
11/15/2020389,600 shares $798,680.00 +10.9%N/A1 $2.05
10/30/2020351,300 shares $751,782.00 +66.8%N/A0.6 $2.14
10/15/2020210,600 shares $494,910.00 -32.1%N/A0.3 $2.35
9/30/2020310,000 shares $722,300.00 -42.8%N/A0.3 $2.33
9/15/2020542,000 shares $1.36 million -22.9%N/A0.3 $2.51
8/31/2020702,900 shares $1.71 million +0.8%N/A0.4 $2.43
8/14/2020697,200 shares $1.95 million -1.5%N/A0.4 $2.79
7/31/2020708,100 shares $2.59 million +4.9%N/A0.4 $3.66
7/15/2020675,200 shares $1.38 million +279.8%N/A0.4 $2.04
6/30/2020177,800 shares $357,378.00 +389.8%N/A0.1 $2.01
6/15/202036,300 shares $47,190.00 +32.0%N/A0 $1.30
5/29/202027,500 shares $34,375.00 +17.0%N/A0 $1.25
5/15/202023,500 shares $20,846.85 -56.4%N/A0 $0.89
4/30/202053,900 shares $51,205.00 +257.0%N/A0.1 $0.95
4/15/202015,100 shares $12,620.58 -66.4%N/A0 $0.84
3/31/202044,900 shares $42,655.00 -38.0%N/A0.3 $0.95

PDSB Short Interest - Frequently Asked Questions

What is PDS Biotechnology's current short interest?

Short interest is the volume of PDS Biotechnology shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 3,860,000 shares of PDSB short. 11.40% of PDS Biotechnology's shares are currently sold short. Learn More on PDS Biotechnology's current short interest.

What is a good short interest ratio for PDS Biotechnology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PDSB shares currently have a short interest ratio of 6.0. Learn More on PDS Biotechnology's short interest ratio.

Which institutional investors are shorting PDS Biotechnology?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of PDS Biotechnology: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for PDS Biotechnology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.40% of PDS Biotechnology's floating shares are currently sold short.

Is PDS Biotechnology's short interest increasing or decreasing?

PDS Biotechnology saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 3,860,000 shares, a decrease of 17.3% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does PDS Biotechnology's short interest compare to its competitors?

11.40% of PDS Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PDS Biotechnology: SOPHiA GENETICS SA (0.09%), Neurogene Inc. (12.59%), Contineum Therapeutics, Inc. (5.87%), Checkpoint Therapeutics, Inc. (14.22%), LifeVantage Co. (15.90%), Neumora Therapeutics, Inc. (23.02%), CARGO Therapeutics, Inc. (18.87%), Amarin Co. plc (2.69%), Tango Therapeutics, Inc. (15.41%), Ocugen, Inc. (24.21%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short PDS Biotechnology stock?

Short selling PDSB is an investing strategy that aims to generate trading profit from PDS Biotechnology as its price is falling. PDSB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against PDS Biotechnology?

A short squeeze for PDS Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PDSB, which in turn drives the price of the stock up even further.

How often is PDS Biotechnology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PDSB, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:PDSB) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners